Source:http://linkedlifedata.com/resource/pubmed/id/19260677
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2009-3-19
|
pubmed:abstractText |
A series of 6-substituted and 5-fluoro-6-substituted uridine derivatives were synthesized and evaluated for their potential as anticancer agents. The designed molecules were synthesized from either fully protected uridine or the corresponding 5-fluorouridine derivatives. The mononucleotide derivatives were used for enzyme inhibition investigations against ODCase. Anticancer activities of all the synthesized derivatives were evaluated using the nucleoside forms of the inhibitors. 5-Fluoro-UMP was a very weak inhibitor of ODCase. 6-Azido-5-fluoro and 5-fluoro-6-iodo derivatives are covalent inhibitors of ODCase, and the active site Lys145 residue covalently binds to the ligand after the elimination of the 6-substitution. Among the synthesized nucleoside derivatives, 6-azido-5-fluoro, 6-amino-5-fluoro, and 6-carbaldehyde-5-fluoro derivatives showed potent anticancer activities in cell-based assays against various leukemia cell lines. On the basis of the overall profile, 6-azido-5-fluoro and 6-amino-5-fluoro uridine derivatives exhibited potential for further investigations.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1520-4804
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
26
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1648-58
|
pubmed:meshHeading |
pubmed-meshheading:19260677-Antineoplastic Agents,
pubmed-meshheading:19260677-Cell Line, Tumor,
pubmed-meshheading:19260677-Crystallography, X-Ray,
pubmed-meshheading:19260677-Drug Screening Assays, Antitumor,
pubmed-meshheading:19260677-Enzyme Inhibitors,
pubmed-meshheading:19260677-Humans,
pubmed-meshheading:19260677-Magnetic Resonance Spectroscopy,
pubmed-meshheading:19260677-Orotidine-5'-Phosphate Decarboxylase,
pubmed-meshheading:19260677-Spectrometry, Mass, Electrospray Ionization,
pubmed-meshheading:19260677-Structure-Activity Relationship
|
pubmed:year |
2009
|
pubmed:articleTitle |
Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents.
|
pubmed:affiliation |
Center for Molecular Design and Preformulations and Division of Cellular and Molecular Biology, Toronto General Research Institute, Toronto General Hospital, Toronto, Ontario M5G 2C4, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|